$ALGN
ALIGN TECHNOLOGY INC

2014 Q4 Form 10-Q Financial Statement

#000109714914000013 Filed on October 30, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $198.6M $189.9M $164.5M
YoY Change 11.39% 15.42% 20.52%
Cost Of Revenue $47.90M $44.82M $39.42M
YoY Change 14.59% 13.72% 9.05%
Gross Profit $150.7M $145.1M $125.1M
YoY Change 10.4% 15.96% 24.65%
Gross Profit Margin 75.88% 76.39% 76.04%
Selling, General & Admin $85.90M $108.9M $72.71M
YoY Change 18.32% 49.82% 18.75%
% of Gross Profit 57.0% 75.1% 58.13%
Research & Development $13.30M $12.85M $10.92M
YoY Change 20.91% 17.76% 9.68%
% of Gross Profit 8.83% 8.86% 8.73%
Depreciation & Amortization $4.400M $4.400M $5.500M
YoY Change 4.76% -20.0% -16.67%
% of Gross Profit 2.92% 3.03% 4.4%
Operating Expenses $99.20M $93.51M $83.63M
YoY Change 18.66% 11.82% -12.75%
Operating Profit $51.50M $51.55M $41.46M
YoY Change -2.65% 24.32% 820.81%
Interest Expense -$1.700M -$2.000M $400.0K
YoY Change -600.0% -200.0%
% of Operating Profit -3.3% -3.88% 0.96%
Other Income/Expense, Net -$1.999M $449.0K
YoY Change -545.21% -227.2%
Pretax Income $49.80M $49.55M $41.91M
YoY Change -5.5% 18.22% 909.95%
Income Tax $10.20M $11.30M $7.376M
% Of Pretax Income 20.48% 22.81% 17.6%
Net Earnings $39.50M $38.25M $34.54M
YoY Change -6.84% 10.74% -10139.83%
Net Earnings / Revenue 19.89% 20.14% 20.99%
Basic Earnings Per Share $0.47 $0.43
Diluted Earnings Per Share $482.9K $0.47 $0.42
COMMON SHARES
Basic Shares Outstanding 80.29M shares 80.63M shares 79.97M shares
Diluted Shares Outstanding 82.01M shares 81.85M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $454.7M $425.5M $323.6M
YoY Change 22.88% 31.5% -1.36%
Cash & Equivalents $199.9M $180.7M $175.8M
Short-Term Investments $254.8M $244.8M $147.7M
Other Short-Term Assets $56.90M $44.10M $34.80M
YoY Change 19.79% 26.72% -1.14%
Inventory $15.93M $15.98M $14.66M
Prepaid Expenses
Receivables $129.8M $130.0M $109.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $657.2M $615.7M $482.3M
YoY Change 20.65% 27.66% -0.41%
LONG-TERM ASSETS
Property, Plant & Equipment $90.13M $86.45M $76.55M
YoY Change 18.99% 12.93% 1.73%
Goodwill $61.37M $82.93M $61.75M
YoY Change -0.41% 34.3% -44.45%
Intangibles $24.36M
YoY Change -47.96%
Long-Term Investments $147.9M $136.0M $76.80M
YoY Change 45.0% 77.08% 269.23%
Other Assets $7.665M $7.513M $8.630M
YoY Change -11.1% -12.94% 219.63%
Total Long-Term Assets $330.8M $332.6M $276.9M
YoY Change 15.09% 20.1% -2.46%
TOTAL ASSETS
Total Short-Term Assets $657.2M $615.7M $482.3M
Total Long-Term Assets $330.8M $332.6M $276.9M
Total Assets $988.0M $948.3M $759.2M
YoY Change 18.73% 24.91% -1.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.25M $24.52M $19.16M
YoY Change 31.21% 27.98% 32.9%
Accrued Expenses $87.88M $86.60M $73.71M
YoY Change 9.38% 17.48% 2.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $201.8M $198.6M $163.3M
YoY Change 15.1% 21.62% 7.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.932M $27.27M $20.25M
YoY Change -35.03% 34.65% 41.53%
Total Long-Term Liabilities $2.932M $27.27M $20.25M
YoY Change -35.03% 34.65% 41.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $201.8M $198.6M $163.3M
Total Long-Term Liabilities $2.932M $27.27M $20.25M
Total Liabilities $235.2M $225.8M $183.5M
YoY Change 18.69% 23.06% 10.56%
SHAREHOLDERS EQUITY
Retained Earnings -$30.51M -$53.14M -$138.3M
YoY Change -68.19% -61.59% 85.86%
Common Stock $8.000K $8.000K $8.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $752.8M $722.5M $575.7M
YoY Change
Total Liabilities & Shareholders Equity $988.0M $948.3M $759.2M
YoY Change 18.73% 24.91% -1.17%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $39.50M $38.25M $34.54M
YoY Change -6.84% 10.74% -10139.83%
Depreciation, Depletion And Amortization $4.400M $4.400M $5.500M
YoY Change 4.76% -20.0% -16.67%
Cash From Operating Activities $71.60M $67.60M $55.20M
YoY Change 6.71% 22.46% 37.31%
INVESTING ACTIVITIES
Capital Expenditures -$7.100M -$7.000M -$5.800M
YoY Change 69.05% 20.69% 1.75%
Acquisitions
YoY Change
Other Investing Activities -$23.10M -$46.80M -$50.40M
YoY Change 255.38% -7.14% 1525.81%
Cash From Investing Activities -$30.20M -$53.80M -$56.20M
YoY Change 182.24% -4.27% 545.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.50M -1.000M 13.00M
YoY Change -282.24% -107.69% 23.81%
NET CHANGE
Cash From Operating Activities 71.60M 67.60M 55.20M
Cash From Investing Activities -30.20M -53.80M -56.20M
Cash From Financing Activities -19.50M -1.000M 13.00M
Net Change In Cash 21.90M 12.80M 12.00M
YoY Change -67.36% 6.67% -71.43%
FREE CASH FLOW
Cash From Operating Activities $71.60M $67.60M $55.20M
Capital Expenditures -$7.100M -$7.000M -$5.800M
Free Cash Flow $78.70M $74.60M $61.00M
YoY Change 10.38% 22.3% 32.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
24517000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17718000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130047000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
113250000 USD
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3949000 USD
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1205000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
80345000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86600000 USD
CY2014Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
10256000 USD
CY2013Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
10100000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1892000 USD
CY2014Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1605000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
294000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
60000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
729578000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
775523000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9910000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7590000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29348000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21265000 USD
CY2013Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.459
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-318000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.449
algn Maturity Period Used To Classify Investments
MaturityPeriodUsedToClassifyInvestments
P27M
CY2014Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
26320000 USD
CY2013Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
26300000 USD
CY2013Q4 us-gaap Assets
Assets
832147000 USD
CY2014Q3 us-gaap Assets
Assets
948289000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
544676000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
615672000 USD
CY2014Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
380837000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
229018000 USD
CY2013Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
127040000 USD
CY2014Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
244820000 USD
CY2013Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
127040000 USD
CY2014Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
244820000 USD
CY2013Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
101978000 USD
CY2014Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
136017000 USD
CY2014Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
136017000 USD
CY2013Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
101978000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
180676000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
242953000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
175839000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
306386000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-130547000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-62277000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80583000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80516000 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80516000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80583000 shares
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
8000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22003000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
106055000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37799000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34911000 USD
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
44822000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
39416000 USD
us-gaap Cost Of Revenue
CostOfRevenue
135272000 USD
us-gaap Cost Of Revenue
CostOfRevenue
120284000 USD
CY2013Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0175
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14501000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20870000 USD
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
87443000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
77275000 USD
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
19714000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15766000 USD
CY2014Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
35400000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12647000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13469000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.29
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
720000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-520000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.228
CY2013Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.176
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
43029000 USD
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
39265000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
18887000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
21849000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
18887000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
21849000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
649000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2600000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2600000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2600000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2600000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
53485000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
53485000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21337000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23739000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28285000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84862000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27487000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
84533000 USD
CY2014Q3 us-gaap Goodwill
Goodwill
82926000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
85362000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
40693000 USD
CY2014Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2013Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2013Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
40693000 USD
us-gaap Gross Profit
GrossProfit
427781000 USD
us-gaap Gross Profit
GrossProfit
361630000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
145054000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
125090000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
41913000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40416000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
49548000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
140592000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18542000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7376000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34301000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11301000 USD
us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
1800000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3788000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24930000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5936000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-671000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
12402000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
9957000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8415000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-467000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2033000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2349000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-256000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4555000 USD
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6009000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
15983000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
13968000 USD
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6240000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5172000 USD
CY2014Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3734000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4241000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
225833000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
198177000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
948289000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
832147000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
175338000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
198560000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-48902000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-46918000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-199989000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-171373000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
155294000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
118864000 USD
us-gaap Net Income Loss
NetIncomeLoss
21874000 USD
us-gaap Net Income Loss
NetIncomeLoss
106291000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
38247000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
34537000 USD
CY2014Q3 us-gaap Noncurrent Assets
NoncurrentAssets
86447000 USD
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
75743000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
449000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-874000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1999000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1491000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Operating Expenses
OperatingExpenses
285698000 USD
us-gaap Operating Expenses
OperatingExpenses
320340000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
93507000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
83626000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
41290000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
142083000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
51547000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
41464000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
24725000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1490000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4346000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
7690000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
8480000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
437000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6854000 USD
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10185000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7513000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8622000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
20000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-191000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
203000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-81000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
171000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-257000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
109000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-155000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
374000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-236000 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-448000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
129000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27273000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22839000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1200000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7368000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2347000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
182000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
77417000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
95105000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3931000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5761000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
350611000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
213990000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7652000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15172000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16957000 USD
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44146000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47465000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28291000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17373000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
32229000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
124101000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
6943000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
72276000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86447000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75743000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12854000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39523000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33113000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10915000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95910000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53135000 USD
CY2014Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
7144000 USD
CY2013Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
6215000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
563053000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
189876000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
164506000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
481914000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
135352000 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52368000 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
45224000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
161642000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
29348000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
21265000 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.358
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.388
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.373
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.002
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0024
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0020
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0020
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
692000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.12
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
4000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
18.33
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.70
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.44
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.15
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
26098000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
719000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1321000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.08
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.40
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
26085000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
719000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
15.39
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
16.88
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y2M12D
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y2M12D
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
25294000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y1M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y1M6D
CY2013Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3104000 USD
CY2012Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4050000 USD
CY2014Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3263000 USD
CY2013Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3806000 USD
CY2013Q4 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
3104000 USD
CY2014Q3 us-gaap Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
3263000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3057000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1370000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2813000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1529000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
598000 shares
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
300000000 USD
us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
222600000 USD
CY2014Q3 algn Future Amortization Expense Thereafter
FutureAmortizationExpenseThereafter
10288000 USD
CY2013Q1 algn Income Tax Expense Benefit Nondeductible Expense Impairment Losses Amount
IncomeTaxExpenseBenefitNondeductibleExpenseImpairmentLossesAmount
40700000 USD
CY2013 algn Marketable Securities Weighted Average Remaining Maturity
MarketableSecuritiesWeightedAverageRemainingMaturity
P11M
CY2014Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
100000 shares
CY2014Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7400000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
633970000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
722456000 USD
CY2014Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
31100000 USD
CY2014Q1 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
8400000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of estimates</font></div><div style="line-height:120%;text-indent:16px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles ("GAAP") in the United States of America (&#8220;U.S.&#8221;) requires our management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes.&#160;Actual results could differ materially from those estimates.&#160;On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, long-lived assets and goodwill, useful lives of intangible assets and property and equipment, stock-based compensation, income taxes, and contingent liabilities, among others.&#160;We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</font></div></div>
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1385000 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1881000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1519000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1957000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82443000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81848000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82014000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82549000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79967000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80592000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80629000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80924000 shares
CY2014Q2 algn Accelerated Share Repurchase Contracted Amountof Repurchase
AcceleratedShareRepurchaseContractedAmountofRepurchase
70000000 USD
CY2014Q2 algn Accelerated Share Repurchase Initial Deliveryof Shares Shares
AcceleratedShareRepurchaseInitialDeliveryofSharesShares
1000000 shares
CY2014Q3 algn Accelerated Share Repurchase Program Final Deliveryof Shares Shares
AcceleratedShareRepurchaseProgramFinalDeliveryofSharesShares
400000 shares
CY2013Q4 algn Accrued Accounts Payable
AccruedAccountsPayable
4053000 USD
CY2014Q3 algn Accrued Accounts Payable
AccruedAccountsPayable
5536000 USD
CY2013Q4 algn Accrued Sales And Marketing Current
AccruedSalesAndMarketingCurrent
3893000 USD
CY2014Q3 algn Accrued Sales And Marketing Current
AccruedSalesAndMarketingCurrent
5397000 USD
CY2013Q4 algn Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
1733000 USD
CY2014Q3 algn Allowance For Doubtful Accounts Receivable And Sales Returns Current
AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent
1813000 USD
algn Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share
EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare
0.28
CY2013Q3 algn Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share
EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare
0.08
CY2014Q3 algn Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share
EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare
0.09
algn Effective Income Tax Rate Reconciliation Tax Holiday Effecton Diluted Earnings Per Share
EffectiveIncomeTaxRateReconciliationTaxHolidayEffectonDilutedEarningsPerShare
0.22
CY2014Q3 algn Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease
FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease
12890000 USD
CY2013Q4 algn Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease
FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease
10488000 USD
CY2014Q3 algn Finite Lived Intangible Assets Accumulated Impairment Loss
FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss
19258000 USD
CY2013Q4 algn Finite Lived Intangible Assets Accumulated Impairment Loss
FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss
19258000 USD
algn Marketable Securities Weighted Average Remaining Maturity
MarketableSecuritiesWeightedAverageRemainingMaturity
P11M
CY2014Q3 algn Operating Leases Future Minimum Payments Due Remainder Of Period
OperatingLeasesFutureMinimumPaymentsDueRemainderOfPeriod
2282000 USD
CY2014Q2 algn Share Repurchase Program Amount Paid
ShareRepurchaseProgramAmountPaid
70000000 USD
algn Standard Product Warranty Time Period
StandardProductWarrantyTimePeriod
P1Y
algn Stock Expectedtobe Repurchased
StockExpectedtobeRepurchased
22600000 USD
CY2014Q2 algn Stock Repurchase Program Authorized Amountfor Next Twelve Months
StockRepurchaseProgramAuthorizedAmountforNextTwelveMonths
100000000 USD
CY2014Q3 algn Stock Repurchased During Period Average Price Per Share
StockRepurchasedDuringPeriodAveragePricePerShare
54.22
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001097149
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
80289814 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ALIGN TECHNOLOGY INC
dei Trading Symbol
TradingSymbol
ALGN

Files In Submission

Name View Source Status
0001097149-14-000013-index-headers.html Edgar Link pending
0001097149-14-000013-index.html Edgar Link pending
0001097149-14-000013.txt Edgar Link pending
0001097149-14-000013-xbrl.zip Edgar Link pending
algn-20140930.xml Edgar Link completed
algn-20140930.xsd Edgar Link pending
algn-20140930_cal.xml Edgar Link unprocessable
algn-20140930_def.xml Edgar Link unprocessable
algn-20140930_lab.xml Edgar Link unprocessable
algn-20140930_pre.xml Edgar Link unprocessable
algn-2014630xex3111.htm Edgar Link pending
algn-2014630xex3121.htm Edgar Link pending
algn-2014630xex3211.htm Edgar Link pending
algn-2014930xq3.htm Edgar Link pending
algn-201493_chartx46929.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending